查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1426386

2024 年软骨成形术全球市场报告

Chondroplasty Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

软骨成形术市场规模预计在未来几年将显着成长。预计到 2028 年将以 5.8% 的复合年增长率 (CAGR) 增长至 172.9 亿美元。预测期内的成长可归因于再生医学的整合、对门诊治疗的重视、新生物材料的引入、肌肉骨骼疾病的增加以及老年人口的扩大。预测期内的主要趋势包括復健技术整合、关节镜技术的采用、软骨修復和再生的进步、手术器械的创新以及导航系统的整合。

在可预见的未来，关节相关疾病的预期激增将成为推动软骨成形术市场扩张的催化剂。这些疾病包括影响关节功能的各种健康问题，通常是由于关节过度使用或突然受伤（例如事故或运动相关事件）引起的。软骨成形术透过解决关节内受损的软骨来治疗这些与关节相关的疾病。 2023 年 8 月《采血针》发表的最新资料强调，痛风（一种影响关节的发炎关节炎）的发生率在英国正在增加。确诊人数从 2021 年 3 月的每 1000 名成人 1.40 例增加到 2022 年 3 月的每 1000 名成人 1.44 例。此外，美国疾病管制与预防中心 (CDC) 2023 年 6 月的预测估计，到 2040 年，美国将有约 7,840 万人 (25.9%) 确诊。 18 岁以上的成年人可能患有医生诊断的关节炎 (BRFSS)。因此，关节相关疾病的盛行率不断上升正在推动软骨成形术市场的成长。

膝盖手术的增加预计将推动未来软骨成形术市场的发展。膝关节手术是指针对膝关节进行的手术干预，以解决影响膝关节功能的各种状况、损伤和疾病。软骨成形术是一种专注于修復和再形成关节内受损软骨的外科手术，特别适用于与膝盖相关的治疗。值得注意的是，根据美国国家医学图书馆的资料，2022年超过1150家机构进行的髋关节和膝关节手术总数较2020年大幅增长18.3%，总合240万例。执行。此外，根据同一来源 2023 年 1 月的预测，全膝关节置换术(TKA) 预计到 2040 年将增加 139%，到 2060 年将增加 469%。随着膝关节手术的增加，对软骨成形术的需求也将随之推高，带动软骨成形术市场的成长。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球软骨成形术市场，依类型、实际及预测细分，2018-2023、2023-2028、2033
  • 射频消融术软骨成形术
  • 脱离软骨成形术
  • 阿特拉软骨成形术
  • 半月软骨修復
  • 组织去除
  • 其他类型
  • 全球软骨成形术市场，依解剖结构、表现及预测细分，2018-2023、2023-2028、2033
  • 膝盖
  • 肩膀
  • 腰部
  • 其他的
  • 全球软骨成形术市场，按设备细分、性能和预测，2018-2023、2023-2028、2033
  • 刮鬍刀
  • 高频装置
  • 关节镜
  • 其他设备
  • 全球软骨成形术市场，依最终用途、实际和预测细分，2018-2023、2023-2028、2033
  • 医院
  • 整形外科诊所
  • 学术研究
  • 其他最终用途

第 7 章 区域与国家分析

  • 全球软骨成形术市场，依地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球软骨成形术市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 软骨成形术市场竞争形势
  • 软骨成形术市场公司概况
    • Johnson &Johnson
    • F. Hoffmann-La Roche Ltd.
    • Osiris Therapeutics Inc.
    • Thermo Fisher Scientific Inc.
    • Takeda Pharmaceutical Company Limited

第31章 其他大型创新公司

  • Medtronic Public Limited Company
  • Stryker Corporation
  • Teva Pharmaceutical Industries Ltd.
  • B. Braun Melsungen AG
  • Zimmer Biomet Holdings Inc.
  • Smith &Nephew plc
  • Sigma-Aldrich Corporation
  • Arthrex Inc.
  • Bio-Rad Laboratories Inc
  • QIAGEN NV
  • CONMED Corporation
  • Promega Corporation
  • Organogenesis Holdings Inc.
  • Bioventus LLC
  • RTI Surgical Holdings Inc.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r13398

Chondroplasty is a surgical procedure designed to repair and reshape damaged cartilage within a joint, commonly performed to alleviate pain and improve joint function in cases of cartilage damage caused by conditions such as osteoarthritis or traumatic injuries.

The main types of chondroplasty include radiofrequency ablation chondroplasty, abrasion chondroplasty, patellar chondroplasty, meniscal repair, tissue removal, and others. Radiofrequency ablation chondroplasty targets minor imperfections in knee cartilage to minimize joint deterioration. Various anatomies, such as knee, shoulder, hip, and others, are addressed using tools such as shavers, radiofrequency devices, and arthroscopes. Chondroplasty procedures are performed in settings such as hospitals, orthopedic clinics, academic research institutions, and others.

The chondroplasty market research report is one of a series of new reports from The Business Research Company that provides chondroplasty market statistics, including chondroplasty industry global market size, regional shares, competitors with a chondroplasty market share, detailed chondroplasty market segments, market trends and opportunities, and any further data you may need to thrive in the chondroplasty industry. This chondroplasty market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chondroplasty market size has grown strongly in recent years. It will grow from $12.92 billion in 2023 to $13.77 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to an increase in sports-related injuries, a preference among patients for non-total joint replacement, advances in postoperative care, enhanced training and expertise among healthcare providers, and a rising incidence of joint disorders.

The chondroplasty market size is expected to see strong growth in the next few years. It will grow to $17.29 billion in 2028 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to the integration of regenerative medicine, a focus on outpatient procedures, the introduction of novel biomaterials, the rise in musculoskeletal disorders, and the expansion of the geriatric population. Major trends in the forecast period include technological integration in rehabilitation, the adoption of arthroscopic techniques, advancements in cartilage repair and regeneration, innovations in surgical tools, and the integration of navigation systems.

The anticipated surge in joint-related disorders stands as a catalyst propelling the expansion of the chondroplasty market in the foreseeable future. These disorders encompass a range of health issues affecting joint functionality, often stemming from excessive joint use or abrupt injuries, such as accidents or sports-related incidents. Chondroplasty serves as a treatment for these joint-related disorders by addressing damaged cartilage within a joint. Recent data published by The Lancet in August 2023 highlighted a rise in the incidence of gout, an inflammatory arthritis impacting joints, in the UK. The diagnoses increased from 1.40 per 1,000 adults in March 2021 to 1.44 per 1,000 adults in March 2022. Furthermore, projections from the Centers for Disease Control and Prevention (CDC) in June 2023 estimate that by 2040, approximately 78.4 million (25.9%) US adults aged 18 years or older may receive doctor-diagnosed arthritis (BRFSS). Hence, the escalating prevalence of joint-related disorders is a driving force behind the chondroplasty market's growth trajectory.

The upswing in knee surgeries is poised to fuel the advancement of the chondroplasty market in the forthcoming period. Knee surgery denotes a surgical intervention targeting the knee joint to address a spectrum of conditions, injuries, or disorders impacting knee functionality. Chondroplasty, a surgical procedure focused on repairing and reshaping damaged cartilage within a joint, finds particular application in knee-related treatments. Notably, data from the National Library of Medicine revealed a substantial 18.3% increase in total hip and knee operations performed at over 1150 facilities in 2022 compared to 2020, totaling 2.4 million procedures. Moreover, projections from the same source in January 2023 indicate a projected surge of 139% in total knee arthroplasty (TKA) by 2040 and a striking 469% surge by 2060. As knee surgeries increase, the demand for chondroplasty is correspondingly boosted, fostering the growth dynamics of the chondroplasty market.

The prospective growth of the chondroplasty market has been hindered by limited reimbursement coverage for chondroplasty procedures. The existing reimbursement policies often impose restrictions on the frequency of chondroplasty treatments a patient can receive, posing challenges, particularly for individuals with recurring or extensive cartilage damage necessitating multiple procedures. Moreover, despite partial coverage, patients often face substantial out-of-pocket expenses, including deductibles, copayments, and coinsurance. These financial burdens may dissuade individuals, especially those facing financial constraints, from pursuing chondroplasty. An article published by the National Library of Medicine in December 2022 reported a concerning trend, a decrease in the average reimbursement rate per CPT code for hip arthroscopy procedures. In 2022, the rate dropped to $899.21, reflecting a notable decrease of $242.24 (21.1%) compared to the inflation-adjusted rate of $1,141.45 in 2011. This limited reimbursement coverage poses a significant obstacle to the expansion of the chondroplasty market.

Key players within the chondroplasty market are actively engaged in developing innovative technologies, such as articular cartilage segmentation tools, to enhance customer service offerings. An articular cartilage segmentation tool is a software application designed to automatically or semi-automatically segment articular cartilage from magnetic resonance imaging (MRI) scans. For example, in July 2021, RSIP Vision, an Israel-based software solution provider, introduced the Articular Cartilage Segmentation Tool. This cutting-edge tool leverages deep learning algorithms to automatically segment cartilage from MRI scans, delivering precise and non-invasive assessments of chondral lesions and cartilage-sparing procedures (such as mosaicplasty, micro-fracture, chondroplasty/osteochondral autograft transfer system, autologous chondrocyte implantation). Physicians utilizing RSIP Vision's module can more accurately evaluate an athlete's cartilage integrity, consequently offering optimal cartilage-sparing treatments. This leads to improved outcomes and shorter recovery times, amplifying the tool's potential to transform patient care within the chondroplasty domain.

In July 2023, Avanos Medical Inc., a prominent US-based company specializing in pain management and chronic care solutions, successfully completed the acquisition of Diros Technology Inc. for a sum totaling $60 million. This strategic acquisition serves to bolster Avanos' standing as a frontrunner in the realm of radiofrequency (RF) technology, expanding its portfolio with a comprehensive range of cutting-edge pain treatment devices. Diros Technology Inc., based in Canada, specializes in crafting radiofrequency devices tailored to address joint disorders such as knee, cervical, and lumbar pain. This acquisition marks a significant step for Avanos, enriching its offerings and solidifying its position within the industry by integrating Diros' expertise and unique devices into its product line.

Major companies operating in the chondroplasty market report are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Osiris Therapeutics Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Medtronic Public Limited Company, Stryker Corporation, Teva Pharmaceutical Industries Ltd., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Sigma-Aldrich Corporation, Arthrex Inc., Bio-Rad Laboratories Inc, QIAGEN N.V., CONMED Corporation, Promega Corporation, Organogenesis Holdings Inc., Bioventus LLC, RTI Surgical Holdings Inc., Vericel Corporation, Geistlich Pharma AG, Ocugen Inc., MEDIPOST Co. Ltd., GPC Medical Ltd., Sklar Surgical Instruments, Isto Biologics, Nebula Inc., NuOrtho Surgical Inc., Medical Devices Business Services Inc.

North America was the largest region in the chondroplasty market in 2023. The regions covered in the chondroplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chondroplasty market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The chondroplasty market includes revenues earned by entities by providing services such as microfracture surgery, laser-assisted treatments, and autologous chondrocyte transplantation (ACT). The market value includes the value of related goods sold by the service provider or included within the service offering. The chondroplasty market also includes sales of radiofrequency ablation devices and autologous chondrocyte implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chondroplasty Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chondroplasty market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chondroplasty? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chondroplasty market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Radiofrequency Ablation Chondroplasty; Abrasion Chondroplasty; Atellar Chondroplasty; Meniscal Repair; Tissue Removal; Other Types
  • 2) By Anatomy: Knee; Shoulder; Hip; Other Anatomies
  • 3) By Equipment: Shavers; Radiofrequency Devices; Arthroscope; Other Equipments
  • 4) By End Use: Hospitals; Orthopedic Clinics; Academic Research; Other End Uses
  • Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Osiris Therapeutics Inc.; Thermo Fisher Scientific Inc.; Takeda Pharmaceutical Company Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chondroplasty Market Characteristics

3. Chondroplasty Market Trends And Strategies

4. Chondroplasty Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Chondroplasty Market Size and Growth

  • 5.1. Global Chondroplasty Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Chondroplasty Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Chondroplasty Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Chondroplasty Market Segmentation

  • 6.1. Global Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Radiofrequency Ablation Chondroplasty
  • Abrasion Chondroplasty
  • Atellar Chondroplasty
  • Meniscal Repair
  • Tissue Removal
  • Other Types
  • 6.2. Global Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Knee
  • Shoulder
  • Hip
  • Other Anatomies
  • 6.3. Global Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Shavers
  • Radiofrequency Devices
  • Arthroscope
  • Other Equipments
  • 6.4. Global Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Orthopedic Clinics
  • Academic Research
  • Other End Use

7. Chondroplasty Market Regional And Country Analysis

  • 7.1. Global Chondroplasty Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Chondroplasty Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Chondroplasty Market

  • 8.1. Asia-Pacific Chondroplasty Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Chondroplasty Market

  • 9.1. China Chondroplasty Market Overview
  • 9.2. China Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Chondroplasty Market

  • 10.1. India Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Chondroplasty Market

  • 11.1. Japan Chondroplasty Market Overview
  • 11.2. Japan Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Chondroplasty Market

  • 12.1. Australia Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Chondroplasty Market

  • 13.1. Indonesia Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Chondroplasty Market

  • 14.1. South Korea Chondroplasty Market Overview
  • 14.2. South Korea Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Chondroplasty Market

  • 15.1. Western Europe Chondroplasty Market Overview
  • 15.2. Western Europe Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Chondroplasty Market

  • 16.1. UK Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Chondroplasty Market

  • 17.1. Germany Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Chondroplasty Market

  • 18.5. France Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Chondroplasty Market

  • 19.9. Italy Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Chondroplasty Market

  • 20.13. Spain Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Chondroplasty Market

  • 21.1. Eastern Europe Chondroplasty Market Overview
  • 21.2. Eastern Europe Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Chondroplasty Market

  • 22.1. Russia Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Chondroplasty Market

  • 23.1. North America Chondroplasty Market Overview
  • 23.2. North America Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Chondroplasty Market

  • 24.1. USA Chondroplasty Market Overview
  • 24.2. USA Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Chondroplasty Market

  • 25.1. Canada Chondroplasty Market Overview
  • 25.2. Canada Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Chondroplasty Market

  • 26.1. South America Chondroplasty Market Overview
  • 26.2. South America Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Chondroplasty Market

  • 27.1. Brazil Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Chondroplasty Market

  • 28.1. Middle East Chondroplasty Market Overview
  • 28.2. Middle East Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Chondroplasty Market

  • 29.1. Africa Chondroplasty Market Overview
  • 29.2. Africa Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Chondroplasty Market Competitive Landscape And Company Profiles

  • 30.1. Chondroplasty Market Competitive Landscape
  • 30.2. Chondroplasty Market Company Profiles
    • 30.2.1. Johnson & Johnson
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Osiris Therapeutics Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Thermo Fisher Scientific Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Takeda Pharmaceutical Company Limited
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Chondroplasty Market Other Major And Innovative Companies

  • 31.1. Medtronic Public Limited Company
  • 31.2. Stryker Corporation
  • 31.3. Teva Pharmaceutical Industries Ltd.
  • 31.4. B. Braun Melsungen AG
  • 31.5. Zimmer Biomet Holdings Inc.
  • 31.6. Smith & Nephew plc
  • 31.7. Sigma-Aldrich Corporation
  • 31.8. Arthrex Inc.
  • 31.9. Bio-Rad Laboratories Inc
  • 31.10. QIAGEN N.V.
  • 31.11. CONMED Corporation
  • 31.12. Promega Corporation
  • 31.13. Organogenesis Holdings Inc.
  • 31.14. Bioventus LLC
  • 31.15. RTI Surgical Holdings Inc.

32. Global Chondroplasty Market Competitive Benchmarking

33. Global Chondroplasty Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Chondroplasty Market

35. Chondroplasty Market Future Outlook and Potential Analysis

  • 35.1 Chondroplasty Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Chondroplasty Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Chondroplasty Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer